INDIANAPOLIS, IN – ĢƵios and Lilly today announced the launch of Lilly Scholars @ ĢƵios, a scholarship program primarily supporting first generation students and students who have overcome socioeconomic barriers who are pursuing credentials in quality, pharmaceutical manufacturing, or related industries.
The program aims to provide approximately 1,000 eligible ĢƵios students, or Lilly Scholars, with financial assistance and experiential learning opportunities that include summer programs and/or work study programs. The program will also support Lilly Scholars with customized education and training at the Lilly Smart Manufacturing Lab, a world-class facility which will be built to support ĢƵios Indianapolis with manufacturing certification and 2-year manufacturing degree options.
“Today, we are taking our partnership with Lilly to the next level with the creation of Lilly Scholars at ĢƵios,” said President of ĢƵios, Dr. Sue Ellspermann. “Lilly Scholars provides high school and adult students with a unique opportunity to leverage the world-class education at ĢƵios with an exceptional employer partner in Lilly and put their education to work in high-wage, high-demand careers that contribute to the growth and prosperity of our state.”
The quality and pharmaceutical manufacturing industries contribute significantly to Indiana's economy, providing high-paying jobs and driving innovation in areas such as biopharmaceuticals, vaccines, and medical devices.
"Today's announcements demonstrate the strong collaboration between industry, academia and government in Indiana," said Edgardo Hernandez, executive vice president and president, Lilly Manufacturing Operations. "Through our new academic commitment, we're looking to grow life sciences education in the state and foster a diverse pipeline of local talent to fill the new jobs created through our recent investments."
Click to learn more about Lilly Scholars @ ĢƵios or to request more information about the program.
About Lilly
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit and or follow us on , and .
About ĢƵios
ĢƵios is Indiana's largest public postsecondary institution and the nation's largest singly accredited statewide community college system, accredited by the Higher Learning Commission. ĢƵios has campuses throughout Indiana and also serves thousands of students annually online. It serves as the state's engine of workforce development, offering associate degrees, long- and short-term certificate programs, industry certifications, and training that aligns with the needs of the community. The College provides a seamless transfer to other colleges and universities in Indiana, as well as out of state, for a more affordable route to a bachelor's degree.
